Evidence map›Paper›PMID 35625230›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Antimicrobial Dispensing Practice in Community Pharmacies in Russia during the COVID-19 Pandemic.

Svetlana Rachina, Roman Kozlov, Anastasiya Kurkova, Ulyana Portnyagina, Shamil Palyutin, Aleksandr Khokhlov, Olga Reshetko, Marina Zhuravleva, Ivan Palagin, On Behalf Of Russian Working Group Of The Project

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Svetlana RachinaInternal Medicine Department #2, First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0002-3329-7846
Roman KozlovInstitute of Antimicrobial Chemotherapy, Smolensk State Medical University, 214019 Smolensk, Russia.
Anastasiya KurkovaInstitute of Antimicrobial Chemotherapy, Smolensk State Medical University, 214019 Smolensk, Russia.
Ulyana PortnyaginaDepartment of Internal Medicine and General Medical Practice, North-Eastern Federal University, 677007 Yakutsk, Russia.
Shamil PalyutinDepartment of Clinical Pharmacology and Drug Ethics, UNESCO, Yaroslavl State Medical University, 150000 Yaroslavl, Russia.
Aleksandr KhokhlovDepartment of Clinical Pharmacology and Drug Ethics, UNESCO, Yaroslavl State Medical University, 150000 Yaroslavl, Russia.
Olga ReshetkoDepartment of Pharmacology, Saratov State Medical University n.a. V.I. Razumovsky, 410012 Saratov, Russia.
Marina ZhuravlevaDepartment of Pharmacology and Propedeutics of Internal Diseases, First Moscow State Medical University, 119991 Moscow, Russia.
Ivan PalaginInstitute of Antimicrobial Chemotherapy, Smolensk State Medical University, 214019 Smolensk, Russia.ORCID 0000-0001-9613-9717
On Behalf Of Russian Working Group Of The Project
Smolensk State Medical University · RUSechenov University · RUNorth-Eastern Federal University · RUSaratov State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has had a significant impact on health care systems, including drug use. The present study aimed to evaluate the patterns of community supply of antimicrobials from community pharmacies during the COVID-19 pandemic in five cities of Russia. In a cross-sectional study, a random sample of pharmacies reported all episodes of antimicrobials supply during a one-week period. Patterns of supply (age and gender of customer, drug name and formulation, prescription availability, indication, etc.) were analyzed. Altogether, 71 pharmacies took part in the study and 5270 encounters were recorded. In total, 4.2% of visits resulted in supply of more than one antimicrobial agent and 5.2% were for parenteral formulations. The rate of prescription-based purchase in participated cities varied from 40.5 to 99.1%. Systemic antibiotics and antivirals accounted for the majority of supplies (60.5 and 26.3%, respectively). Upper respiratory tract infections were reported as the indication for antimicrobials usage in 36.9% of cases, followed by skin and soft tissue infections (12.1%) and urinary tract infections (8.7%); COVID-19 accounted for 8.4% of all supplies. Amoxicillin with clavulanic acid, azithromycin and amoxicillin were indicated as the top three antimicrobials purchased for upper respiratory tract infections, and azithromycin, umifenovir and levofloxacin were the top three for COVID-19. In general, a high rate of drugs dispensing without prescription was revealed. Antibiotics for systemic use remained the most common antimicrobials, whereas presumably viral upper respiratory tract infections were the main reason for their purchase. COVID-19 infection itself was responsible for a small proportion of the supply of antimicrobial agents, but systemic antibiotics accounted for more than a half of supplies.

Indexed as

antibioticsantimicrobials supplyantiviralscommunity pharmaciesCOVID-19

Identifiers

PMID35625230
PMCPMC9137661
OpenAlexW4225147186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.